Exactech Knee, Hip and Shoulder Innovations Presented at the 2014 Orthopaedic Research Society Annual Meeting
March 24 2014 - 10:00AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, presented scientific posters and presentations
regarding its latest advancements for shoulder and knee replacement
surgery during the 2014 Orthopaedic Research Society annual meeting
in New Orleans.
Four posters presented Exactech’s Optetrak Logic® knee systems
as well as the ExactechGPS®, a novel computer-assisted guidance
system for total knee arthroplasty:
- Angibaud, L. et al. Accuracy of a Novel
Computer-Assisted Guided System for Total Knee Arthroplasty. Trans.
of the 60th Annual ORS Meeting, Poster #0968, 2014.
- Angibaud, L. et al. Evaluation of the
Alignment Discrepancies during Total Knee Arthroplasty Using an
Image-free Computer-assisted Guidance System. Trans. of the 60th
Annual ORS Meeting, Poster #1858, 2014.
- Gao, B. et al. Rotational Constraint
Comparison between Two TKA Prostheses - Evaluation Using Computer
Simulation. Trans. of the 60th Annual ORS Meeting, Poster #0973,
2014.
- Gardner, A. et al. Unicondylar Wear
Test without Cruciate Ligament Resistance. Trans. of the 60th
Annual ORS Meeting, Poster #1827, 2014.
One poster detailed the impingement performance of Exactech’s
Connexion GXL® acetabular liners:
- Loftus, E. Impingement Performance of a
Moderately Cross-Linked UHMWPE Liner. Trans. of the 60th Annual ORS
Meeting, Poster #1783, 2014.
Additionally, six posters presented the biomechanical advantages
of Exactech’s Equinoxe® shoulder system, the fastest growing
shoulder replacement system in the U.S.:
- Roche, C. et al. Comparison of Bone
Removed with Reverse Total Shoulder Arthroplasty. Trans. of the
60th Annual ORS Meeting, Poster #1894, 2014.
- Flurin, PH. et al. A Comparison and
Correlation of Clinical Outcome Metrics in Anatomic and Reverse
Total Shoulder Arthroplasty. Trans. of the 60th Annual ORS Meeting,
Poster #0992, 2014.
- Jacobson, A. et al. Humeral Anatomy
Study: A Comparison of Male and Female Shoulders with Similar
Average Age and BMI. Trans. of the 60th Annual ORS Meeting, Poster
#0997, 2014.
- Roche, C. et al. Restoring Rotator Cuff
Muscle Tension in Patients with Posterior Glenoid Wear using Total
Shoulder Arthroplasty. Trans. of the 60th Annual ORS Meeting,
Poster # 0534, 2014.
- Roche, C. et al. Reverse Shoulder
Glenoid Baseplate Fixation: A Comparison of Flat-Back vs Curve-Back
Designs and Oval vs Round Designs with 2 Different Offset
Glenospheres. Trans. of the 60th Annual ORS Meeting, Poster #0956,
2014.
- Greene, A. et al. Scapula Anatomy Study
with Consideration to Reverse Shoulder Arthroplasty Biomechanics
and Design. Trans. of the 60th Annual ORS Meeting, Poster #0999,
2014.
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorMedia
contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Apr 2023 to Apr 2024